T-type Ca2+ channel blockers suppress the growth of human cancer cells.Bioorg Med Chem Lett. 2008 Jul 15; 18(14):3899-901.BM
Abstract
In order to further clarify the role of T-type Ca(2+) channels in cell proliferation, we have measured the growth inhibition of human cancer cells by using our potent T-type Ca(2+) channel blockers. As a result, KYS05090, a most potent T-type Ca(2+) channel blocker, was found to be as potent as doxorubicin against some human cancer cells without acute toxicity. Therefore, this letter provides the biological results that T-type calcium channel is important in regulating the important cellular phenotype transition leading to cell proliferation, and thus novel T-type Ca(2+) channel blocker presents new prospects for cancer treatment.
Links
MeSH
Pub Type(s)
Journal Article
Research Support, Non-U.S. Gov't
Language
eng
PubMed ID
18585035
Citation
Heo, Jae Ho, et al. "T-type Ca2+ Channel Blockers Suppress the Growth of Human Cancer Cells." Bioorganic & Medicinal Chemistry Letters, vol. 18, no. 14, 2008, pp. 3899-901.
Heo JH, Seo HN, Choe YJ, et al. T-type Ca2+ channel blockers suppress the growth of human cancer cells. Bioorg Med Chem Lett. 2008;18(14):3899-901.
Heo, J. H., Seo, H. N., Choe, Y. J., Kim, S., Oh, C. R., Kim, Y. D., Rhim, H., Choo, D. J., Kim, J., & Lee, J. Y. (2008). T-type Ca2+ channel blockers suppress the growth of human cancer cells. Bioorganic & Medicinal Chemistry Letters, 18(14), 3899-901. https://doi.org/10.1016/j.bmcl.2008.06.034
Heo JH, et al. T-type Ca2+ Channel Blockers Suppress the Growth of Human Cancer Cells. Bioorg Med Chem Lett. 2008 Jul 15;18(14):3899-901. PubMed PMID: 18585035.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - T-type Ca2+ channel blockers suppress the growth of human cancer cells.
AU - Heo,Jae Ho,
AU - Seo,Han Na,
AU - Choe,Yun Jeong,
AU - Kim,Sujin,
AU - Oh,Chun Rim,
AU - Kim,Young Deuk,
AU - Rhim,Hyewhon,
AU - Choo,Dong Joon,
AU - Kim,Jungahn,
AU - Lee,Jae Yeol,
Y1 - 2008/06/14/
PY - 2008/05/20/received
PY - 2008/06/06/revised
PY - 2008/06/11/accepted
PY - 2008/7/1/pubmed
PY - 2008/11/18/medline
PY - 2008/7/1/entrez
SP - 3899
EP - 901
JF - Bioorganic & medicinal chemistry letters
JO - Bioorg Med Chem Lett
VL - 18
IS - 14
N2 - In order to further clarify the role of T-type Ca(2+) channels in cell proliferation, we have measured the growth inhibition of human cancer cells by using our potent T-type Ca(2+) channel blockers. As a result, KYS05090, a most potent T-type Ca(2+) channel blocker, was found to be as potent as doxorubicin against some human cancer cells without acute toxicity. Therefore, this letter provides the biological results that T-type calcium channel is important in regulating the important cellular phenotype transition leading to cell proliferation, and thus novel T-type Ca(2+) channel blocker presents new prospects for cancer treatment.
SN - 1464-3405
UR - https://www.unboundmedicine.com/medline/citation/18585035/T_type_Ca2+_channel_blockers_suppress_the_growth_of_human_cancer_cells_
DB - PRIME
DP - Unbound Medicine
ER -